Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Free Articles

These articles are provided free to all readers.  Other free articles are available in Week in Review, In My Opinion, and Education Center.  To have access to all of our articles, click here...

Week in Review: South Korea's Celltrion Plans $513 Million Biologics Facility in Wuhan

Week in Review: China's I-Mab Stages $104 Million NASDAQ IPO

BeiGene Announces $160 Million Agreement for China Rights to Two EUSA Orphan Biologics

Week in Review: Four China Biopharmas Announce $100+ Million Deals in First Week of 2020

Week in Review: Shanghai's I-Mab Plans $100 Million NASDAQ IPO on January 16

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China